cdmo.directory
← Compare landing

CMIC HOLDINGS Co., Ltd. vs Viralgen

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cmicgroup/viralgen

CategoryCMIC HOLDINGS Co., Ltd.Viralgen
Listed sitebothcdmo
SummaryCMIC HOLDINGS is a Japanese healthcare group whose Pharmaceutical Solutions cover consulting, non-clinical CRO, CRO, CDMO, SMO and CSO services. The group says it supports pharmaceutical companies across the value chain from non-clinical stages through post-marketing.Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Clinical Trial Services
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
ModalitiesData not yet provided.
  • AAV / Viral Vector Platform
  • Gene Therapy
IndicationsData not yet provided.
  • Rare Disease
LocationsData not yet provided.
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
CertificationsData not yet provided.
  • EMA · Identifier: AEMPS/EMA certified
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.